Literature DB >> 11423566

Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

Guillermo Pérez DE Lema1, Holger Maier1, Elena Nieto2, Volker Vielhauer1, Bruno Luckow1, Francisco Mampaso2, Detlef Schlöndorff1.   

Abstract

Lupus nephritis is characterized by immune complex deposition and inflammatory cell infiltration. Therefore, the initiation and progression of lupus nephritis in MRL/MpJ Fas(lpr/lpr) (MRL/lpr) mice were investigated, with a focus on the expression of several chemokines and chemokine receptors. Mice were monitored for proteinuria from 6 to 20 wk of age, and kidneys were examined every 2 wk by light microscopy, electron microscopy, and immunohistologic analyses. Furthermore, the expression of chemokines, chemokine receptors, and proinflammatory cytokines was analyzed in ribonuclease protection assays. MRL/lpr mice demonstrated increased expression of monocyte chemoattractant protein-1, regulated upon activation, normal T cell-expressed and -secreted protein, inducible protein of 10 kD, and macrophage inflammatory protein-1beta at week 8. At that time point, levels of circulating and glomerular immune complexes were increased, and no proteinuria or histopathologic signs of renal damage could be observed. As assessed in immunohistochemical and in situ hybridization analyses, monocyte chemoattractant protein-1 and regulated upon activation, normal T cell-expressed and -secreted protein expression was preferentially located in the glomeruli and interstitium. Mononuclear cell infiltration of the kidney was observed by weeks 10 to 12. At week 12, the renal expression of chemokine receptor 1 (CCR1), CCR2, and CCR5 was increased, mice became proteinuric, and renal damage was histologically evident. Finally, the expression of proinflammatory cytokines was detected (weeks 12 to 14). In summary, (1) chemokines are upregulated before inflammatory cell infiltration, proteinuria, and kidney damage are observed; (2) chemokine generation is restricted to sites of subsequent inflammatory cell infiltration, i.e., glomeruli and interstitium; (3) chemokine receptor expression parallels mononuclear cell infiltration; and (4) proinflammatory cytokines are upregulated later, in parallel with inflammatory cell infiltration and the onset of proteinuria. These results support the hypothesis that chemokines initiate leukocyte infiltration and precede proteinuria and renal damage in MRL/lpr mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423566     DOI: 10.1681/ASN.V1271369

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  79 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

2.  Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.

Authors:  Chunsun Dai; Xiaoyan Wen; Weichun He; Youhua Liu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells.

Authors:  Pouran Habibzadegah-Tari; Karen G Byer; Saeed R Khan
Journal:  Urol Res       Date:  2006-01-06

4.  CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.

Authors:  Mohd Hafeez Faridi; Samia Q Khan; Wenpu Zhao; Ha Won Lee; Mehmet M Altintas; Kun Zhang; Vinay Kumar; Andrew R Armstrong; Carmelo Carmona-Rivera; Jessica M Dorschner; Abigail M Schnaith; Xiaobo Li; Yogita Ghodke-Puranik; Erica Moore; Monica Purmalek; Jorge Irizarry-Caro; Tingting Zhang; Rachael Day; Darren Stoub; Victoria Hoffmann; Shehryar Jehangir Khaliqdina; Prachal Bhargava; Ana M Santander; Marta Torroella-Kouri; Biju Issac; David J Cimbaluk; Andrew Zloza; Rajeev Prabhakar; Shashank Deep; Meenakshi Jolly; Kwi Hye Koh; Jonathan S Reichner; Elizabeth M Bradshaw; JianFeng Chen; Luis F Moita; Peter S Yuen; Wanxia Li Tsai; Bhupinder Singh; Jochen Reiser; Swapan K Nath; Timothy B Niewold; Roberto I Vazquez-Padron; Mariana J Kaplan; Vineet Gupta
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

5.  Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.

Authors:  Pradeep Tyagi; Saundra S Motley; Tatsuki Koyama; Mahendra Kashyap; Jeffrey Gingrich; Naoki Yoshimura; Jay H Fowke
Journal:  Prostate       Date:  2017-10-27       Impact factor: 4.104

6.  The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.

Authors:  S Sato; X K Zhang
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis.

Authors:  Yogesh Scindia; Dominika Nackiewicz; Paromita Dey; Agnieszka Szymula; Amandeep Bajwa; Diane L Rosin; W Kline Bolton; Mark D Okusa; Umesh Deshmukh; Harini Bagavant
Journal:  Nephron Exp Nephrol       Date:  2012-10-19

8.  ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Authors:  Jared M Odegard; Leah D DiPlacido; Lark Greenwald; Michael Kashgarian; Dwight H Kono; Chen Dong; Richard A Flavell; Joe Craft
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis.

Authors:  Zhongxin Jiang; Tao Sui; Bin Wang
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

10.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.